Text-only version of this email
LIXTE Biotechnology Holdings, Inc. Investor Relations
The following documents have been filed with the SEC:
SEC FILING ALERT
10-Q: QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D)
HTML PDF
If you have any questions, or would like to contact Investor Relations, please reply to this email.
LIXTE Biotechnology Holdings, Inc.
680 E Colorado Blvd., Suite 180, Pasadena, CA 91101 United States of America
Change Your
Show all